Literature DB >> 24517244

Danger signal adenosine via adenosine 2a receptor stimulates growth of Porphyromonas gingivalis in primary gingival epithelial cells.

R Spooner1, J DeGuzman, K L Lee, O Yilmaz.   

Abstract

Extracellular signaling during inflammation and chronic diseases involves molecules referred to as 'Danger Signals' (DS), including the small molecule adenosine. We demonstrate that primary gingival epithelial cells (GEC) express a family of G-protein coupled receptors known as adenosine receptors, including the high-affinity receptors A1 and A2a and low-affinity receptors A2b and A3. Treatment of Porphyromonas gingivalis-infected GEC with the A2a receptor-specific agonist CGS-21680 resulted in elevated intracellular bacterial replication as determined by fluorescence microscopy and antibiotic protection assay. Additionally, A2a receptor antagonism and knockdown via RNA interference significantly reduced metabolically active intracellular P. gingivalis. Furthermore, analysis of anti-inflammatory mediator cyclic AMP (cAMP) following A2a receptor selective agonist CGS-21680 stimulation induced significantly higher levels of cAMP during P. gingivalis infection, indicating that adenosine signaling may attenuate inflammatory processes associated with bacterial infection. This study reveals that the GEC express functional A2a receptor and P. gingivalis may use the A2a receptor coupled DS adenosine signaling as a means to establish successful persistence in the oral mucosa, possibly via downregulation of the pro-inflammatory response.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  A2a receptor; epithelial mucosa; periodontal disease; persistence; purinergic signaling

Mesh:

Substances:

Year:  2014        PMID: 24517244      PMCID: PMC3960722          DOI: 10.1111/omi.12045

Source DB:  PubMed          Journal:  Mol Oral Microbiol        ISSN: 2041-1006            Impact factor:   3.563


  37 in total

1.  Activation of adenosine-receptor-enhanced iNOS mRNA expression by gingival epithelial cells.

Authors:  S Murakami; N Yoshimura; H Koide; J Watanabe; M Takedachi; M Terakura; M Yanagita; T Hashikawa; T Saho; Y Shimabukuro; H Okada
Journal:  J Dent Res       Date:  2002-04       Impact factor: 6.116

Review 2.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Authors:  M J L Bours; E L R Swennen; F Di Virgilio; B N Cronstein; P C Dagnelie
Journal:  Pharmacol Ther       Date:  2006-06-19       Impact factor: 12.310

3.  A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence.

Authors:  M S Alam; C C Kurtz; J M Wilson; B R Burnette; E B Wiznerowicz; W G Ross; J M Rieger; R A Figler; J Linden; S E Crowe; P B Ernst
Journal:  Mucosal Immunol       Date:  2009-03-04       Impact factor: 7.313

4.  Adenosine receptor stimulation by polynucleotides (PDRN) reduces inflammation in experimental periodontitis.

Authors:  Alessandra Bitto; Giacomo Oteri; Michele Pisano; Francesca Polito; Natasha Irrera; Letteria Minutoli; Francesco Squadrito; Domenica Altavilla
Journal:  J Clin Periodontol       Date:  2012-10-03       Impact factor: 8.728

5.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

6.  Targeting the inflammasome and adenosine type-3 receptors improves outcome of antibiotic therapy in murine anthrax.

Authors:  Serguei G Popov; Taissia G Popova; Fatah Kashanchi; Charles Bailey
Journal:  World J Biol Chem       Date:  2011-05-26

7.  Lipoteichoic acid from Staphylococcus aureus increases matrix metalloproteinase 9 expression in RAW 264.7 macrophages: modulation by A2A and A2B adenosine receptors.

Authors:  Luiz Fernando de Souza; Fernanda Rafaela Jardim; Ismael Pretto Sauter; Marcela Moreira de Souza; Fabiano Barreto; Rogério Margis; Elena Aida Bernard
Journal:  Mol Immunol       Date:  2008-10-31       Impact factor: 4.407

8.  Porphyromonas gingivalis-nucleoside-diphosphate-kinase inhibits ATP-induced reactive-oxygen-species via P2X7 receptor/NADPH-oxidase signalling and contributes to persistence.

Authors:  Chul Hee Choi; Ralee Spooner; Jefferson DeGuzman; Theofilos Koutouzis; David M Ojcius; Özlem Yilmaz
Journal:  Cell Microbiol       Date:  2013-01-09       Impact factor: 3.715

Review 9.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

10.  Staphylococcus aureus synthesizes adenosine to escape host immune responses.

Authors:  Vilasack Thammavongsa; Justin W Kern; Dominique M Missiakas; Olaf Schneewind
Journal:  J Exp Med       Date:  2009-09-28       Impact factor: 14.307

View more
  18 in total

1.  CD73-dependent adenosine dampens interleukin-1β-induced CXCL8 production in gingival fibroblasts: Association with heme oxygenase-1 and adenosine monophosphate-activated protein kinase.

Authors:  Erivan Schnaider Ramos-Junior; Michael Pedram; Renee E Lee; Drake Exstrom; Özlem Yilmaz; Robson Coutinho-Silva; David M Ojcius; Ana Carolina Morandini
Journal:  J Periodontol       Date:  2019-08-12       Impact factor: 6.993

2.  A1 adenosine receptor signaling reduces Streptococcus pneumoniae adherence to pulmonary epithelial cells by targeting expression of platelet-activating factor receptor.

Authors:  Manmeet Bhalla; Jun Hui Yeoh; Claire Lamneck; Sydney E Herring; Essi Y I Tchalla; Lauren R Heinzinger; John M Leong; Elsa N Bou Ghanem
Journal:  Cell Microbiol       Date:  2019-11-20       Impact factor: 3.715

3.  Prelude to oral microbes and chronic diseases: past, present and future.

Authors:  Kalina R Atanasova; Özlem Yilmaz
Journal:  Microbes Infect       Date:  2015-03-24       Impact factor: 2.700

Review 4.  The inflammasome and danger molecule signaling: at the crossroads of inflammation and pathogen persistence in the oral cavity.

Authors:  Özlem Yilmaz; Kyu Lim Lee
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

Review 5.  Key Elements of Gingival Epithelial Homeostasis upon Bacterial Interaction.

Authors:  J S Lee; Ö Yilmaz
Journal:  J Dent Res       Date:  2020-11-17       Impact factor: 6.116

6.  In Situ Intraepithelial Localizations of Opportunistic Pathogens, Porphyromonas gingivalis and Filifactor alocis, in Human Gingiva.

Authors:  Jaden S Lee; Ralee Spooner; Nityananda Chowdhury; Vivek Pandey; Bridgette Wellslager; Kalina R Atanasova; Zachary Evans; Özlem Yilmaz
Journal:  Curr Res Microb Sci       Date:  2020-05-15

7.  In Situ Anabolic Activity of Periodontal Pathogens Porphyromonas gingivalis and Filifactor alocis in Chronic Periodontitis.

Authors:  Ralee Spooner; Kris M Weigel; Peter L Harrison; KyuLim Lee; Gerard A Cangelosi; Özlem Yilmaz
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

Review 8.  Modulation of inflammasome activity by Porphyromonas gingivalis in periodontitis and associated systemic diseases.

Authors:  Ingar Olsen; Özlem Yilmaz
Journal:  J Oral Microbiol       Date:  2016-02-04       Impact factor: 5.474

9.  Nucleoside-Diphosphate-Kinase of P. gingivalis is Secreted from Epithelial Cells In the Absence of a Leader Sequence Through a Pannexin-1 Interactome.

Authors:  Kalina Atanasova; Jungnam Lee; JoAnn Roberts; Kyulim Lee; David M Ojcius; Özlem Yilmaz
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

Review 10.  Porphyromonas gingivalis: major periodontopathic pathogen overview.

Authors:  Jaroslav Mysak; Stepan Podzimek; Pavla Sommerova; Yelena Lyuya-Mi; Jirina Bartova; Tatjana Janatova; Jarmila Prochazkova; Jana Duskova
Journal:  J Immunol Res       Date:  2014-03-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.